(2022) Billing Guidelines For Reclast, Zometa (Concentrate), And Aclasta

(2022) Billing Guidelines For Reclast, Zometa (Concentrate), And Aclasta

Reclast®, Zometa®, Zometa Concentrate®, and Aclasta® can be reported with HCPCS code J3489. According to CMS, J3489 replaced J3487 and J3488 (deleted on 31 December 2013). 1. What Is HCPCS Code J3489? J3489 can be used for billing Reclast®, Zometa®, Zometa Concentrate®, and Aclasta®. These brands contain zoledronic acid, which inhibits the release of calcium…

HCPCS Code J2506 | Description & Billing Guidelines

HCPCS Code J2506 | Description & Billing Guidelines

J2506 describes the drug pegfilgrastim and can be billed for 0.5 milligrams. Biosimilars are excluded. Pegfilgrastim is often administered by subcutaneous injection. What Is J2506? HCPCS code J2506 represents 0.5 mg of pegfilgrastim, excluding biosimilars, typically administered by subcutaneous injection to decrease the chances of infection in patients receiving chemotherapy. The standard dosage of pegfilgrastim is six…

HCPCS Code J1170 For Dilaudid

HCPCS Code J1170 For Dilaudid

J1170 can be reported for an injection of hydromorphone with a maximum of four milligrams. 1. Description J1170 is officially described by HCPCS as: “Injection, hydromorphone, up to 4 mg.” One unit of the J1170 code represents up to 4 mg of hydromorphone. Routes of administration include intramuscular, an injection into muscle; intravenous, an injection,…